77 related articles for article (PubMed ID: 20530412)
1. Evidence of a tumour suppressor function for DLEC1 in human breast cancer.
Al Sarakbi W; Reefy S; Jiang WG; Roberts T; Newbold RF; Mokbel K
Anticancer Res; 2010 Apr; 30(4):1079-82. PubMed ID: 20530412
[TBL] [Abstract][Full Text] [Related]
2. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a tumour suppressive function of APRG1 in breast cancer.
Leris AC; Roberts TR; Jiang WG; Newbold RF; Mokbel K
Breast Cancer Res Treat; 2005 Sep; 93(2):97-100. PubMed ID: 16187228
[TBL] [Abstract][Full Text] [Related]
4. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.
Worku D; Jouhra F; Jiang GW; Patani N; Newbold RF; Mokbel K
Anticancer Res; 2008; 28(4B):2135-9. PubMed ID: 18751386
[TBL] [Abstract][Full Text] [Related]
5. The missing kiss of life: transcriptional activity of the metastasis suppressor gene KiSS1 in early breast cancer.
Kostadima L; Pentheroudakis G; Pavlidis N
Anticancer Res; 2007; 27(4B):2499-504. PubMed ID: 17695545
[TBL] [Abstract][Full Text] [Related]
6. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
Zhang Y; Miao Y; Yi J; Wang R; Chen L
Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
[TBL] [Abstract][Full Text] [Related]
7. mRNA Expression of
Gera R; Mokbel L; Jiang WG; Mokbel K
Cancer Genomics Proteomics; 2018; 15(6):447-452. PubMed ID: 30343278
[TBL] [Abstract][Full Text] [Related]
8. The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Anticancer Res; 2012 Feb; 32(2):671-4. PubMed ID: 22287761
[TBL] [Abstract][Full Text] [Related]
9. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer.
Subramanian A; Sharma AK; Banerjee D; Jiang WG; Mokbel K
Anticancer Res; 2007; 27(5B):3513-8. PubMed ID: 17972510
[TBL] [Abstract][Full Text] [Related]
11. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance.
Cheng S; Douglas-Jones A; Yang X; Mansel RE; Jiang WG
Cancer Genomics Proteomics; 2010; 7(2):67-73. PubMed ID: 20335520
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J
J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048
[TBL] [Abstract][Full Text] [Related]
13. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
14. The mRNA expression of DAP1 in human breast cancer: correlation with clinicopathological parameters.
Wazir U; Jiang WG; Sharma AK; Mokbel K
Cancer Genomics Proteomics; 2012; 9(4):199-201. PubMed ID: 22798505
[TBL] [Abstract][Full Text] [Related]
15. The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters.
Al Sarakbi W; Sasi W; Jiang WG; Roberts T; Newbold RF; Mokbel K
BMC Cancer; 2009 Aug; 9():290. PubMed ID: 19698110
[TBL] [Abstract][Full Text] [Related]
16. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
[TBL] [Abstract][Full Text] [Related]
17. SIRT2: tumour suppressor or tumour promoter in operable breast cancer?
McGlynn LM; Zino S; MacDonald AI; Curle J; Reilly JE; Mohammed ZM; McMillan DC; Mallon E; Payne AP; Edwards J; Shiels PG
Eur J Cancer; 2014 Jan; 50(2):290-301. PubMed ID: 24183459
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma.
Kwong J; Chow LS; Wong AY; Hung WK; Chung GT; To KF; Chan FL; Daigo Y; Nakamura Y; Huang DP; Lo KW
Genes Chromosomes Cancer; 2007 Feb; 46(2):171-80. PubMed ID: 17099870
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1.
Guo Y; Shu L; Zhang C; Su ZY; Kong AN
Biochem Pharmacol; 2015 Mar; 94(2):69-78. PubMed ID: 25640947
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival.
Ye C; Cai Q; Dai Q; Shu XO; Shin A; Gao YT; Zheng W
Cancer; 2007 May; 109(9):1729-35. PubMed ID: 17366603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
